BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16858173)

  • 1. Aripiprazole-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH).
    Bachu K; Godkar D; Gasparyan A; Sircar P; Yakoby M; Niranjan S
    Am J Ther; 2006; 13(4):370-2. PubMed ID: 16858173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-induced hyponatremia: case report and literature review.
    Kohen I; Voelker S; Manu P
    Am J Ther; 2008; 15(5):492-4. PubMed ID: 18806526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndrome of inappropriate antidiuretic hormone associated with aripiprazole.
    Yam FK; Jackson EA; Kwan BK
    Am J Health Syst Pharm; 2013 Dec; 70(23):2110-4. PubMed ID: 24249761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A challenging case of syndrome of inappropriate secretion of antidiuretic hormone in an elderly patient secondary to quetiapine.
    Atalay A; Turhan N; Aki OE
    South Med J; 2007 Aug; 100(8):832-3. PubMed ID: 17713312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The syndrome of inappropriate antidiuretic hormone secretion (SIADH) during treatment with the antipsychotic agents haloperidol and quetiapine].
    van den Heuvel OA; Bet PM; van Dam EW; Eeckhout AM
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1944-8. PubMed ID: 16999280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole-induced parkinsonism.
    Sharma A; Sorrell JH
    Int Clin Psychopharmacol; 2006 Mar; 21(2):127-9. PubMed ID: 16421466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic.
    Keck PE; McElroy SL
    Expert Opin Investig Drugs; 2003 Apr; 12(4):655-62. PubMed ID: 12665420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the safety and tolerability of aripiprazole.
    Pae CU
    Expert Opin Drug Saf; 2009 May; 8(3):373-86. PubMed ID: 19505266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole-induced hyponatremia: a case report.
    Behere RV; Venkatasubramanian G; Naveen MN; Gangadhar BN
    J Clin Psychiatry; 2007 Apr; 68(4):640-1. PubMed ID: 17474829
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyponatremia secondary to SIADH in a schizophrenic patient treated with Quetiapine.
    Kumar PNS; Gopalakrishnan A
    Asian J Psychiatr; 2018 Jun; 35():89-90. PubMed ID: 29803963
    [No Abstract]   [Full Text] [Related]  

  • 12. The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia.
    Kim SW; Shin IS; Kim JM; Youn T; Yang SJ; Hwang MY; Yoon JS
    Clin Neuropharmacol; 2009; 32(4):224-6. PubMed ID: 19644229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
    Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent hiccups associated with switching from risperidone to aripiprazole in a schizophrenic patient with cerebral palsy.
    Yeh YW
    Clin Neuropharmacol; 2011; 34(4):135-6. PubMed ID: 21768798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action.
    Stahl SM
    J Clin Psychiatry; 2001 Dec; 62(12):923-4. PubMed ID: 11780870
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole and neuroleptic malignant syndrome.
    Chakraborty N; Johnston T
    Int Clin Psychopharmacol; 2004 Nov; 19(6):351-3. PubMed ID: 15486522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole associated urine retention in a male schizophrenia patient.
    Hsu WY; Chang TG; Chiu NY
    Gen Hosp Psychiatry; 2013; 35(6):680.e11-2. PubMed ID: 23932666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the Frequency and Onset Time of Hyponatremia/Syndrome of Inappropriate Antidiuretic Hormone Induced by Antidepressants or Antipsychotics.
    Takeda K; Kobayashi C; Nakai T; Oishi T; Okada A
    Ann Pharmacother; 2022 Mar; 56(3):303-308. PubMed ID: 34210184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic.
    Buckley PF
    Drugs Today (Barc); 2003 Feb; 39(2):145-51. PubMed ID: 12698209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.